跳至主要内容
临床试验/NCT06070649
NCT06070649
招募中
1 期

The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)

Yale University2 个研究点 分布在 1 个国家目标入组 63 人2025年8月4日

概览

阶段
1 期
干预措施
0.3mg/kg/min Dimethyltryptamine + Normal Saline infusion
疾病 / 适应症
Alcohol Use Disorder (AUD)
发起方
Yale University
入组人数
63
试验地点
2
主要终点
Safety and tolerability of DMT in women and men with AUD
状态
招募中
最后更新
4天前

概览

简要总结

This proposed study is a double-blind, randomized, placebo-controlled, parallel-group, laboratory study to determine the effects of DMT, plus psychotherapy, on Alcohol Use Disorder.

详细描述

This study is a placebo-controlled, randomized, double blind, clinical trial to investigate the safety, tolerability and efficacy of the psychedelic dimethyltryptamine (DMT), in addition to a short course of psychotherapy, on Alcohol Use Disorder (AUD). The investigators hypothesize that relative to control (0.2 mg/kg/min + Dimethyltryptamine 0.01mg/kg/min infusion plus psychotherapy), a single psychedelic dose of DMT (plus psychotherapy) in individuals with AUD will 1) be safe and 2) well-tolerated, and 3) reduce alcohol consumption measured in the laboratory the day after, and over the following 8 weeks.

注册库
clinicaltrials.gov
开始日期
2025年8月4日
结束日期
2026年8月1日
最后更新
4天前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

责任方
Principal Investigator
主要研究者

Anahita Bassir Nia

Assistant Professor of Psychiatry

Yale University

入排标准

入选标准

  • Diagnostic and Statistical Manual of Mental Disorders-5th edition (DSM-5) diagnosis of Alcohol Use Disorder
  • Medically healthy
  • Ability to provide consent

排除标准

  • Unstable medical conditions

研究组 & 干预措施

Group 1

Bolus of 0.3mg/kg/min DMT (5min) + Normal Saline infusion (60 min)

干预措施: 0.3mg/kg/min Dimethyltryptamine + Normal Saline infusion

Group 2

Bolus of 0.2 mg/kg/min DMT (5 min) + 0.01mg/kg/min infusion (60 min)

干预措施: 0.2 mg/kg/min + Dimethyltryptamine 0.01mg/kg/min infusion

Group 3

Bolus of 25 mg Diphenhydramine (5 min) + Normal Saline infusion (60 min)

干预措施: 25 mg Diphenhydramine (5 min) + Normal Saline

结局指标

主要结局

Safety and tolerability of DMT in women and men with AUD

时间窗: Day 0 through Day 56

Systematic Assessment for Treatment Emergent Effects (SAFTEE) and MedDRA will be used weekly for 8 weeks to assess safety and tolerability of DMT in women and men with AUD.

The effects of DMT, plus psychotherapy, on alcohol consumption

时间窗: Day 0 through Day 56

We will assess the desire of participants to drink alcohol in an experimental setting using the Alcohol Drinking Paradigm.

次要结局

  • The relationship between acute psychedelic effects of DMT and alcohol consumption(Day 0 through Day 56)
  • The relationship between the intensity of subjective psychedelic experience with lifetime history of chronic stress and trauma(Day 0 through Day 56)
  • The long-term effects of a single dose of DMT, plus psychotherapy, on alcohol consumption over the subsequent 8 weeks.(Day 0 through Day 56)
  • The prosocial effects of DMT, plus psychotherapy, and changes in personality traits(Day 0 through Day 56)

研究点 (2)

Loading locations...

相似试验